Shanton to Present Topline Data from Phase 2b Study with SAP-001 in Refractory Gout Patients at EULAR 2025 Congress
SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., May 19, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment...
Microvast at CIBF 2025: Powering What's Next
STAFFORD, Texas, May 19, 2025 /PRNewswire/ -- Microvast Holdings, Inc. (NASDAQ: MVST) ("Microvast" or the "Company"), a global leader in advanced battery technologies, has highlighted its comprehensive suite of high-performance battery products at...
Ant Digital Technologies Debuts AI-Powered FinTech Solutions at Dubai FinTech Summit 2025
Introducing the latest "Agentar" and a comprehensive AI for FinTech product suite, showcasing revolutionary AI innovations to propel financial inclusion and operational efficiency DUBAI, UAE, May 13, 2025 /PRNewswire/ -- Ant Digital Technologies, a...
AccurEdit Therapeutics to present at the 2025 Annual Meeting of the American Society of Gene & Cell Therapy
SUZHOU, China, May 12, 2025 /PRNewswire/ -- AccurEdit Therapeutics today announced that its three abstracts have been selected for presentation, including one oral presentation on ART001, at the upcoming American Society of Gene & Cell Therapy...
Shoplazza Partners with Power Commerce and Monri Payments at Balkan eCommerce Summit 2025 to Accelerate Regional Growth
SOFIA, Bulgaria, May 12, 2025 /PRNewswire/ -- Shoplazza, a leading global SaaS eCommerce platform, successfully wrapped up its participation at the Balkan eCommerce Summit 2025 held from April 29-30 at Arena Sofia. Invited by strategic regional...
NEXTG ARTECH EXHIBITION TO OPEN IN NYC
An Immersive Exploration at the Intersection of Art, Technology, and Civilization NEW YORK, May 8, 2025 /PRNewswire/ -- On May 9, 2025, the NextG ARTECH Exhibition will officially open its doors to the public at 445 Park Avenue in New York City,...
Innovent Announces Oral Presentation of Full Phase 2 Clinical Data for Efdamrofusp Alfa (IBI302), First-in-class anti-VEGF/complement Bispecific Fusion Protein at ARVO 2025
SAN FRANCISCO and SUZHOU, China, May 6, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...
DJI Agriculture's Annual Report Reveals Drone-Powered Farming Revolution at Brazil's Agrishow 2025
Approximately 400,000 agricultural drones in use by 400,000 trained operators to treat 300 types of crops in 100 countries SHENZHEN, China, April 30, 2025 /PRNewswire/ -- DJI, the world leader in civilian drones and creative camera technology, today...
Mabwell Releases 6 Study Results of Innovative Drugs and Platforms at the 2025 AACR Annual Meeting
SHANGHAI, April 30, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, presented 6 study results of innovative drugs and platforms in poster format at the American Association for...
HL Mando Recognized as 2024 Supplier of the Year by General Motors
SEOUL, South Korea and LAS VEGAS, April 30, 2025 /PRNewswire/ -- On April 8, 2025, General Motors presented HL Mando with a 2024 Supplier of the Year Award at GM's 33rd annual Supplier of the Year event in Phoenix, Arizona. (From the left) Min-Chul...